Global biopharmaceutical company AstraZeneca commits to reach net-zero greenhouse gas emissions across the value chain by FY2045. Near-Term Targets Global biopharmaceutical company AstraZeneca commits to reduce absolute scope 1 and 2 GHG emissions 98% by FY2026 from a FY2015 base year, and to reduce absolute scope 3 GHG emissions 50% by FY2030 from a FY2019 base year. Within this target, AstraZeneca commits to reduce absolute scope 3 GHG emissions from fuel and energy related activities, upstream leased assets and downstream leased assets 80% by FY2030; from use of sold products 95% by 2030; and from upstream transportation and distribution, waste generated in operations, business travel, employee commuting and end of life treatment of sold products 46% by FY2030, all from a 2019 base year. Furthermore, AstraZeneca commits that 95% of its suppliers by spend covering purchased goods and services and capital goods, and 50% of its suppliers by spend covering upstream transportation and distribution and business travel, will have science-based targets by FY2025. Long-Term Targets AstraZeneca also commits to reduce absolute scope 3 GHG emissions 90% by FY2045 from a FY2019 base year.